Lu AG22515
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu AG22515, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease [Phase 1]